ADAM17 and hepatocellular carcinoma: It shows reduced expression in HCC and HCC-derived cell lines and culminates in hepatocarcinogenesis by targeting genes namely CCNG1, SRF, IGF1R, BCL2L2 and ADAM17 [18–20].